The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 550.00
Bid: 547.00
Ask: 550.00
Change: 6.00 (1.10%)
Spread: 3.00 (0.548%)
Open: 540.00
High: 550.00
Low: 538.00
Prev. Close: 544.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Team Acquisition

13 Feb 2020 07:00

RNS Number : 8371C
Polar Capital Holdings PLC
13 February 2020
 

13 February 2020

 

 

Polar Capital Holdings plc

to acquire International and World equity strategies

 

 

Polar Capital Holdings plc ("Polar Capital") announces it has reached agreement to acquire from Los Angeles based asset manager First Pacific Advisors, LP ("FPA") its International Value and World Value equity team led by Pierre Py and Greg Herr ("the Managers").

 

Polar Capital and the Managers share common philosophies, being specialist, investment-led active fund managers. Polar Capital offers the team a platform from which together they can build a significant US based international and global equity franchise.

 

Polar Capital will provide global operational support and distribution capabilities in multiple jurisdictions to support the strategies' growth while allowing the Managers to continue to focus on seeking to deliver exceptional returns to their clients.

 

Polar Capital has made known its desire to build upon its strong UK and European wholesale franchises by attracting specialist active investment strategies that manage products suitable for institutional investors particularly, but not exclusively, in North America. The arrival of Jorry Nøddekær and his Emerging Market team in 2018 is evidence of this strategic intent.

 

The arrival of Pierre, Greg and their team is a natural extension of this strategy and delivers Managers with excellent track records and existing client relationships into an asset class that is complementary to the existing strategies managed by Polar Capital.

 

The team will establish a joint venture with Polar Capital, to be named Phaeacian Partners, with separate branding but with economics consistent with the other investment teams at Polar Capital.

 

As at 31 December 2019, the Managers managed approximately $1bn of assets in three pooled vehicles and three institutional segregated accounts. The FPA Paramount Fund, Inc. and FPA International Value Fund (each, an "FPA Fund"), have delivered top quartile performance in their respective Morningstar mutual fund categories over 3 years, and each has a four-star Morningstar rating.

 

The transaction contemplates that each FPA Fund will be reorganized into a new US series trust organized by Polar Capital. The transaction is subject to all required regulatory, FPA Fund Board and FPA Fund shareholder approvals. Polar Capital, the Managers and FPA will be recommending to the FPA Funds Board, FPA Fund shareholders and all of the Managers' existing clients to transition to the Polar Capital platform.

 

The expectation is that in quarter 3 or 4 of 2020 the transaction will complete with the Managers, their team and their business transferring to Polar Capital and the FPA Funds reorganizing into a newly established series trust organized by Polar Capital.

 

The material quantum of consideration for the transaction will be satisfied in the initial five years by Polar Capital delivering to FPA, from its standard 55% interest, a 25% share of the business's revenues. On the existing $1bn of AUM, core EPS will benefit by circa 0.5p but during the period of the FPA revenue share the benefit to total EPS will be depressed by its existence. As strategy revenues grow EPS will benefit, with the end of the initial five year revenue trail delivering a further gear change of EPS improvement.

 

 

Gavin Rochussen, Chief Executive of Polar Capital, commented,

"This is a very exciting development for Polar Capital that begins to deliver our strategy to develop an international and global product, an institutional presence and to establish a Polar Capital North American bridgehead to complement our existing east coast presence. The establishment of Phaeacian Partners is clear evidence of the delivery of this strategy. Pierre, Greg and their colleagues are precisely the type of team that we have been looking to recruit; a global and international equity team, deploying a fundamental value style of investing with an excellent track record, with existing institutional support and significant growth potential."

 

Pierre Py and Greg Herr commented,

"We are delighted to have found in Polar Capital an organisation that is so complementary to us and our ambition. We look forward with excitement and confidence to growing a significant business with Polar Capital based upon our top performing, well tested and long term international and global equity investment processes."

 

J. Richard Atwood, Managing Partner of FPA, commented,

"We are excited to have found Polar and to maintain a continued financial interest in the success of the International Value and World Value strategies. Polar's business model is the right fit for Pierre and Greg as they pursue growth with institutional and overseas investors. We are glad to have identified and launched strategies that have added value for clients and believe this is an ideal alignment of interests for all stakeholders, particularly current investors in these strategies."

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (Executive Director)

Samir Ayub (Finance Director)

+44 (0)20 7227 2700

 

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

 

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Guy Wiehahn

Andrew Buchanan

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

Monique Perks

 

 

+44 (0)20 3757 4995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQDBGDDUGBDGGD
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.